NanoString Releases High-Resolution FFPE Tissue Dataset Generated Using New CosMx Spatial Molecular Imager

RNA expression from almost 1,000 genes mapped at single cell and subcellular resolution within non-small cell lung cancer samples SEATTLE -- NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the first public release of data generated by the CosMx™ Spatial Molecular Imager (SMI). The [...]

Biognosys Launches Next-Generation Blood Biomarker Discovery Solution

The new and improved service will offer unprecedented depth, precision, and throughput, quantifying up to 3,000 proteins in plasma or serum SCHLIEREN, (Zurich, Switzerland). Biognosys, a leader in proteomics solutions for drug discovery and development, today announces the launch of its next-generation blood biomarker discovery solution, which will be offered as a contract research service. [...]

DNA Script to Develop Next Generation of Enzymatic DNA Synthesis Printers with $2.2 Million Grant Award from the National Human Genome Research Institute of the NIH

Designed to bypass the oligo bottleneck in genomic research and development, the new platform will build on the success of DNA Script’s recently launched SYNTAX System using their innovative Enzymatic DNA Synthesis technology SOUTH SAN FRANCISCO, Calif., and PARIS -- DNA Script, a leader in benchtop enzymatic DNA synthesis, today announced that the company has [...]

Quantum-Si Acquires Majelac Technologies to Strengthen Chip Supply Chain

Acquisition expands Quantum-Si’s capabilities in semiconductor chip assembly and packaging GUILFORD, Conn. -- Quantum-Si Incorporated (NASDAQ: QSI) ("Quantum-Si," "QSI" or the "Company"), a life sciences tools company commercializing a unique single molecule protein sequencing platform, today announced that it acquired Majelac Technologies LLC, a privately-owned company providing semiconductor packaging and integrated circuit assembly services. The acquisition [...]

Rapid impurity amplification service announced by YMC.

Finding high end user interest in the unique N-Rich functionality embedded in the Contichrom CUBE instrument, YMC launches an in-house service to amplify minute impurity peaks for end users. Devens, MA USA – YMC America adds to its lab services a program to magnify impurities in small and large biologics. Increasing otherwise minute peaks enables [...]

GlycoPath Inc. Launches Glycan Imaging Kit for Glycoproteomic Analysis of Clinical and Research Samples

CHARLESTON, S.C. -- GlycoPath Inc., developer of advanced bioanalytical assays based on its proprietary GlycoTyper™ immunoaffinity technology, announced their launch of the first research-based kit for N-Glycan Imaging Mass Spectrometry, giving researchers the practical expertise and means to determine the tissue spatial distribution of N-glycans to enhance their biomedical investigations. Each kit not only comes with [...]

Ceres Nanosciences Establishes Nine Wastewater-based COVID-19 Surveillance Centers of Excellence Under NIH RADx Initiative

MANASSAS, Virginia – Ceres Nanosciences (Ceres), a privately held company that makes innovative products to improve life science research and diagnostic testing, is announcing the establishment of nine new wastewater-based epidemiology centers of excellence, as part of the April 2021 $8.2 million award from the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADxSM) initiative. [...]

China’s gene-editing landscape advances as CVC’s second CRISPR/Cas9 patent granted New patent covers methods and compositions for use of CRISPR/Cas9 in eukaryotes.

Dublin, Ireland: ERS Genomics Limited (‘ERS’) is pleased to report that China Patent No. 2017105856905 has been granted. This new patent covers methods and compositions for use of CRISPR/Cas9 in eukaryotes. ERS, co-founded by Dr. Emmanuelle Charpentier, 2020 Nobel Prize winner for gene-editing, provides access to the foundational CRISPR/Cas9 intellectual property. With this patent in China, the fundamental [...]

Accenture Invests in Geneyx to Expand the Use of Genetic Data for Targeted and Personalized Therapeutics and Diagnostics

NEW YORK -- Accenture (NYSE: ACN) has made a strategic investment, through Accenture Ventures, in Geneyx Genomex Ltd. (Geneyx), an Israel-based developer of genomic analysis and interpretation software. Geneyx helps improve patient outcomes associated with hereditary and rare diseases by providing disease-specific, clinically relevant insights around risk prediction, diagnosis, prognosis, and treatment for clinical and pharmaceutical organizations. Today, [...]

RIGAKU’S NEW MINIFLEX XPC, IDEALLY SUITED FOR ROUTINE QUALITY CONTROL OPERATIONS

Rigaku Corporation (Tokyo, Japan) are proud to unveil their new MiniFlex XpC X-ray diffractometer (XRD) at the prestigious JASIS analytical instruments tradeshow in Chiba, Japan. The MiniFlex XpC has been optimized for high-throughput quality control applications in industrial environments, bringing lab quality performance to the manufacturing floor. Primarily designed for the cement industry, it is also suited for applications [...]

Access IBO on Knowledge Center